THEME: "Advancing Research, Enhancing Patient Outcomes"
12-13 Oct 2026
Bali, Indonesia Biomarkers and advanced diagnostic tools enable early detection, precise classification, and real-time monitoring of hematologic and vascular diseases. Using molecular signatures, genetic profiling, high-resolution imaging, and novel laboratory assays, clinicians can identify disease mechanisms, predict treatment response, and personalize therapy. These innovations improve diagnostic accuracy, support targeted treatment strategies, and enhance overall patient care.